PeptideWellness
Take the quiz
§ By goal
§ Most read
Featured · field guide
The 2026 GLP-1 telehealth field guide.

Where the category stands in May 2026 — what's available, who to trust, what costs what. 22-min read, medically reviewed.

Read the guide
§ The providers
Who sells what — and who to trust.

An independent overview of the compounded-GLP-1 telehealth market and the providers we cover — market size, what the FDA changed, and an honest read on each.

View the provider overviewAll 17 reviews
§ Learn
The educational layer, in progress.

Primers for newcomers and deep dives for the curious. The foundation articles are published; more are in the pipeline.

View all Learn articles
§ Interactive tools
60-second quiz PeptideMatch Start here Answer four questions, get a goal-matched protocol and provider. The record GLP-1 price history Every price change we have recorded, with the figure before and after it. Overview All tools The full tools page — quiz, the Index, its history, and how we build them. Method How we measure a price What counts as the price, where we read it, and how often it is re-checked.
Free to use Medically reviewed methodology How we build our tools
PeptideWellness Index
The GLP-1 Price Index

What compounded and branded semaglutide and tirzepatide actually cost, from each provider's own published pricing.

See the full index
§ Legal · Medical disclaimer

Medical disclaimer

Last updated: June 2026

PeptideWellness is an independent editorial publication. Everything we publish is for general information and education. It is not medical advice, and it does not replace a consultation with a licensed healthcare provider who knows your history.

Not medical advice

Our articles, reviews, comparisons, and tools are informational. They don't diagnose, treat, or prescribe, and reading them doesn't create a doctor–patient relationship. Decisions about starting, changing, or stopping any peptide therapy or medication should be made with a licensed clinician familiar with your medical history. Never disregard or delay professional medical advice because of something you read here. If you think you may have a medical emergency, contact your doctor or emergency services.

Compounded and investigational substances

Many compounds we cover are compounded or investigational. Compounded medications are not FDA-approved and do not undergo the same safety, effectiveness, or manufacturing review as branded pharmaceuticals. Some peptides we describe are research-only and not approved for human use; where that's the case, we say so. Coverage of any substance is not an endorsement or a recommendation that it is safe or appropriate for you.

Individual results and risk

Evidence in this category is uneven and still developing, and individual responses vary. Reported benefits in studies or by manufacturers are not guarantees, and side effects and contraindications differ from person to person. Any decision you make based on information here is at your own discretion and risk.

Accuracy and updates

We work to keep clinical information accurate and current and to source it to primary references, as described in our methodology. Even so, guidance, regulatory status, and availability change — sometimes quickly — and we can't guarantee every page reflects the latest position at the moment you read it. If you spot a clinical claim you believe is wrong or out of date, write to editorial@peptidewellnessusa.com.

We review this page as our coverage changes, and update the date above when we do.

Our methodology Terms of use